Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
A randomised controlled trial of patient self management of oral anticoagulation compared to standard care
ISRCTN ISRCTN19313375
DOI 10.1186/ISRCTN19313375
ClinicalTrials.gov identifier
EudraCT number
Public title A randomised controlled trial of patient self management of oral anticoagulation compared to standard care
Scientific title
Acronym SMART: Self-Management of Anticoagulation, a Randomised Trial
Serial number at source G9900263
Study hypothesis The null hypothesis is that patients managing their own anticoagulation can achieve as good therapeutic control as patients receiving standard care.

Please note that as of 07/02/2007 this record was updated to include the current target number of participants. The previous target number of participants at the time of registration was 660.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Anticoagulant therapy
Participants - inclusion criteria All patients aged over 18 receiving warfarin therapy
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/09/2000
Anticipated end date 30/06/2003
Status of trial Completed
Patient information material
Target number of participants 512
Interventions The intervention comprises a training programme to enable patients to undertake oral anticoagulation monitoring at home.
Primary outcome measure(s) 1. Therapeutic international normalised ratio (INR) control
2. Bleeding and thrombotic complications
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (UK)
Trial website
Publications 1. 2003 protocol in http://www.ncbi.nlm.nih.gov/pubmed/13678426
2. 2005 results in http://www.ncbi.nlm.nih.gov/pubmed/16216821
3. 2011 results in http://www.ncbi.nlm.nih.gov/pubmed/21068191
Contact name Mr  A  Fitzmaurice
  Address The Department of Primary Care and General Practice
The Medical School
The University of Birmingham
  City/town Birmingham
  Zip/Postcode B15 2TT
  Country United Kingdom
  Email
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 23/10/2000
Last edited 21/07/2011
Date ISRCTN assigned 23/10/2000
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.